Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 31.3% – Here’s What Happened

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) fell 31.3% during mid-day trading on Wednesday . The stock traded as low as C$0.14 and last traded at C$0.17. 1,643,425 shares changed hands during trading, an increase of 198% from the average session volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Down 31.3 %

The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The company has a market capitalization of C$23.01 million, a PE ratio of -16.50 and a beta of 0.32. The firm has a fifty day simple moving average of C$0.10 and a 200-day simple moving average of C$0.07.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.